David W Meline Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David W Meline.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David W Meline. David W Meline is a EVP & CFO in AMGEN INC ($AMGN) and a Former Sr. VP & CFO in 3M CO ($MMM) and a SR VP & CHIEF FINANCIAL OFCR in 3M CO ($MMM) and a VP CORP CNTRLR & CF ACCTG OFCR in 3M CO ($MMM) and a Director in ZF TRW AUTOMOTIVE HOLDINGS CORP ($TRW) and a Chief Financial Officer in Moderna, Inc. ($MRNA).
Address: 3M CENTER ST PAUL 55144-1000 MN
Companies in which David W Meline is an Insider
3M CO
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of David W Meline: Former Sr. VP & CFO, SR VP & CHIEF FINANCIAL OFCR, VP CORP CNTRLR & CF ACCTG OFCR
Holdings: 1,000 shares
Current Value: $175,760
Latest Transaction: Jun 11 2014
$MMM Market Capitalization: $105.66B
$MMM Previous Close: $175.76
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AMGEN INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of David W Meline: EVP & CFO
Holdings: 49,378 shares
Current Value: $8,237,238
Latest Transaction: Nov 25 2019
$AMGN Market Capitalization: $124.07B
$AMGN Previous Close: $166.82
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Moderna, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of David W Meline: Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Feb 11 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ZF TRW AUTOMOTIVE HOLDINGS CORP
Industry: MOTOR VEHICLE PARTS & ACCESSORIES [3714]
Position of David W Meline: Director
Holdings: 0 shares
Latest Transaction: May 15 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of David W Meline
Sentiment: All, MMM, AMGN, MRNA, TRW
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11 2021 | MRNA | Moderna, Inc. | Meline David W | Chief Financial Off ... | Option Exercise | A | 0.00 | 5,570 | 0 | 5,570 | |
| Feb 11 2021 | MRNA | Moderna, Inc. | Meline David W | Chief Financial Off ... | Option Exercise | A | 179.52 | 25,618 | 4,598,943 | 25,618 | |
| Jan 11 2021 | MRNA | Moderna, Inc. | Meline David W | Chief Financial Off ... | Option Exercise | A | 59.15 | 271,303 | 16,047,572 | 271,303 | |
| Nov 25 2019 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Sell | S | 234.36 | 8,737 | 2,047,603 | 49,378 | 58.1 K to 49.4 K (-15.03 %) |
| May 07 2019 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Option Exercise | A | 177.31 | 39,382 | 6,982,822 | 39,382 | |
| May 07 2019 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Grant | A | 0.00 | 4,511 | 0 | 57,903 | 53.4 K to 57.9 K (+8.45 %) |
| May 07 2019 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Payment of Exercise | F | 176.50 | 795 | 140,318 | 53,392 | 54.2 K to 53.4 K (-1.47 %) |